| Net Cash Provided by (Used in) Operating Activities |
$22,103 |
USD |
52% |
Q2 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$12,302 |
USD |
-63% |
Q2 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
4,450,000,000 |
shares |
1.1% |
Q4 2024 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,831,310,013 |
shares |
361% |
Q4 2024 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$397 |
USD |
97% |
Q2 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$458,197 |
USD |
349% |
Q4 2024 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q2 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$13,353 |
USD |
-92% |
Q4 2024 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.17 |
pure |
0% |
Q2 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$13,353 |
USD |
-92% |
Q4 2024 |
Q3 2025 |
| Depreciation |
$1,886 |
USD |
-49% |
Q4 2024 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$654,425 |
USD |
-417% |
Q4 2024 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q2 2024 |
Q1 2025 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q2 2024 |
Q1 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
Q3 2025 |
| Additional Paid in Capital |
$21,742,333 |
USD |
|
Q4 2024 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
Q3 2025 |
| Interest Expense |
$2,717 |
USD |
|
Q2 2024 |
Q1 2025 |